1. Home
  2. ASMB vs MCHX Comparison

ASMB vs MCHX Comparison

Compare ASMB & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • MCHX
  • Stock Information
  • Founded
  • ASMB 2005
  • MCHX 2003
  • Country
  • ASMB United States
  • MCHX United States
  • Employees
  • ASMB N/A
  • MCHX N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • ASMB Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • ASMB Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • ASMB 84.5M
  • MCHX 84.3M
  • IPO Year
  • ASMB 2010
  • MCHX 2004
  • Fundamental
  • Price
  • ASMB $13.02
  • MCHX $2.07
  • Analyst Decision
  • ASMB Buy
  • MCHX
  • Analyst Count
  • ASMB 2
  • MCHX 0
  • Target Price
  • ASMB $35.00
  • MCHX N/A
  • AVG Volume (30 Days)
  • ASMB 20.5K
  • MCHX 33.9K
  • Earning Date
  • ASMB 03-27-2025
  • MCHX 03-13-2025
  • Dividend Yield
  • ASMB N/A
  • MCHX N/A
  • EPS Growth
  • ASMB N/A
  • MCHX N/A
  • EPS
  • ASMB N/A
  • MCHX N/A
  • Revenue
  • ASMB $28,326,000.00
  • MCHX $48,594,000.00
  • Revenue This Year
  • ASMB $282.16
  • MCHX N/A
  • Revenue Next Year
  • ASMB N/A
  • MCHX $4.63
  • P/E Ratio
  • ASMB N/A
  • MCHX N/A
  • Revenue Growth
  • ASMB N/A
  • MCHX N/A
  • 52 Week Low
  • ASMB $11.03
  • MCHX $1.11
  • 52 Week High
  • ASMB $19.93
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 40.89
  • MCHX 60.01
  • Support Level
  • ASMB $12.10
  • MCHX $1.88
  • Resistance Level
  • ASMB $14.25
  • MCHX $2.04
  • Average True Range (ATR)
  • ASMB 0.60
  • MCHX 0.09
  • MACD
  • ASMB -0.10
  • MCHX 0.01
  • Stochastic Oscillator
  • ASMB 35.11
  • MCHX 90.48

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: